Fastigium

Fastigium biotechnology will consist of improving the in vivo transfection of mRNA by optimizing the endocytosis of LNPs and the escape of mRNA from endosomes.

 Last news

our-mrna-platform-page

Messenger Biopharma in Lyonbiopole’s newsletter

posted December 22, 2016

  Please click on this ...Read More